Quelicin, Anectine vs. Atracurium

• Are Quelicin, Anectine and Atracurium the Same Thing?
• What Are Possible Side Effects of Quelicin, Anectine?
• What Are Possible Side Effects of Atracurium?
• What Is Quelicin, Anectine?
• What Is Atracurium?
• What Drugs Interact with Quelicin, Anectine?
• What Drugs Interact with Atracurium?
• How Should Quelicin, Anectine Be Taken?
• How Should Atracurium Be Taken?

Quelicin and Anectine (succinylcholine chloride) and atracurium besylate injection are skeletal muscle relaxants used as adjuncts to general anesthesia to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Side effects of Quelicin and Anectine and atracurium besylate that are similar include fast or slow heart rate and low blood pressure.

Side effects of Quelicin and Anectine that are different from atracurium besylate include cardiac arrest, dangerously fast rise in body temperature, arrhythmias, high blood pressure, high levels of potassium in the blood, prolonged respiratory depression or apnea, increased eye pressure, muscle twitching, jaw rigidity, postoperative muscle pain, acute kidney failure, excessive salivation, and rash.

Side effects of atracurium besylate that are different from Quelicin and Anectine include skin flushing or redness, injection site reactions, hives, itching, wheezing, shortness of breath, allergic reactions, and inadequate musculoskeletal block.

Both Quelicin and Anectine and atracurium besylate may interact with antibiotics, quinidine, procainamide, lithium, isoflurane, and magnesium salts.

Quelicin and Anectine may also interact with promazine, oxytocin, aprotinin, p-adrenergic blockers, lidocaine, trimethaphan, quinine, chloroquine, diethylether, desflurane, metoclopramide, terbutaline, oral contraceptives, glucocorticoids, and monoamine oxidase inhibitors.

Atracurium besylate may also interact with enflurane, halothane, other muscle relaxants, and succinylcholine.

Common side effects of Quelicin, Anectine include:

• cardiac arrest,
• dangerously fast rise in body temperature (malignant hyperthermia),
• arrhythmias,
• slow or rapid heart rate,
• high or low blood pressure,
• high levels of potassium in the blood,
• prolonged respiratory depression or apnea,
• increased intraocular (eye) pressure,
• muscle twitching,
• jaw rigidity,
• postoperative muscle pain,
• acute kidney (renal) failure,
• excessive salivation, and,
• rash.

Common side effects of Atracurium include:

• headache,
• sensitivity of the eyes to light, or
• blurred vision

Quelicin, Anectine (succinylcholine chloride) Injection is a short-acting depolarizing skeletal muscle relaxant used as an adjunct to general anesthesia to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Atracurium (loteprednol etabonate and tobramycin) is a combination of a corticosteroid and an antibiotic used to treat eye inflammation caused by surgery, infection, allergies, and other conditions. Common side effects of Atracurium include stinging, burning, irritation, itching, discomfort, or redness of the eyes for 1 to 2 minutes when this medication is applied.

Quelicin may interact with promazine oxytocin aprotinin antibiotics quinidine p-adrenergic blockers procainamide lidocaine trimethaphan lithium carbonate magnesium salts quinine chloroquine diethylether isoflurane desflurane metoclopramide terbutaline oral contraceptives glucocorticoids or monoamine oxidase inhibitors. Tell your doctor all medications and supplements you use. During pregnancy Quelicin should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Atracurium besylate injection may interact with enflurane, isoflurane, halothane, antibiotics, lithium, magnesium salts, procainamide, quinidine, other muscle relaxants, and succinylcholine. Tell your doctor all medications and supplements you use. During pregnancy, atracurium besylate should be used only if prescribed It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

The dosage of Quelicin is individualized and should always be determined by the physician after careful assessment of the patient.

An atracurium besylate dose of 0.4 to 0.5 mg/kg (1.7 to 2.2 times the ED95), given as an intravenous bolus injection, is the recommended initial dose for most patients.